Jill Lee’s Post

Breakthrough with AI. Extremely exciting to see what we can reveal with data and intelligence.

🎙️ New Episode Alert: Exploring the Future of Life Sciences with Lisa V. Sellers PhD - CEO of Vector Laboratories 🧪🌱 In this episode of the Life Science Success Podcast, I had the pleasure of speaking with Lisa V. Sellers, PhD, the dynamic CEO of Vector Laboratories. Join us as we dive into Lisa's career journey, her approach to leadership, and the exciting future of life sciences. With over two decades of experience in the industry, Lisa has risen through the ranks, from product manager to CEO. Her expertise lies in running global life science tools businesses and developing innovative strategies that deliver exceptional results. Lisa's unique leadership style enables her to tap into the full potential of her talented teams. Vector Laboratories, a renowned company specializing in bioconjugation, serves a diverse range of sectors such as drug development, diagnostics, and life science tools. With 45 years of expertise, Vector Laboratories strikes a perfect balance between stability and the agility of a startup. One of Lisa's biggest challenges as CEO revolves around managing people's adaptability in an ever-changing industry. To tackle this, she prioritizes comprehensive onboarding programs, mentorship opportunities, and community engagement. Lisa also seeks to broaden perspectives by blending community service with coaching and mentoring, collaborating with local schools. Lisa's excitement for the future of life sciences lies in the convergence of genomics and proteomics. She envisions an integrated understanding of biology that paves the way for groundbreaking discoveries. She also emphasizes the importance of being flexible and open to possibilities to navigate the upcoming changes successfully. Don't miss this insightful episode with Lisa V. Sellers, PhD, as we explore her remarkable journey as CEO of Vector Laboratories and gain valuable insights into the future of life sciences. Listen now on the Life Science Success Podcast! 🎧🔬 #LifeScienceSuccess #PodcastEpisode #Leadership #Bioconjugation #FutureOfLifeSciences #Genomics #Proteomics #VectorLaboratories #CEOInsights

🎙️ New Episode Alert: Exploring the Future of Life Sciences with Lisa V. S. PhD - CEO of Vector Laboratories, Inc. 🧪🌱 In this episode of the Life Science Success Podcast, I had the pleasure of speaking with Lisa V. Sellers, PhD, the dynamic CEO of Vector Laboratories. Join us as we dive into Lisa's career journey, her approach to leadership, and the exciting future of life sciences. With over two decades of experience in the industry, Lisa has risen through the ranks, from product manager to CEO. Her expertise lies in running global life science tools businesses and developing innovative strategies that deliver exceptional results. Lisa's unique leadership style enables her to tap into the full potential of her talented teams. Vector Laboratories, a renowned company specializing in bioconjugation, serves a diverse range of sectors such as drug development, diagnostics, and life science tools. With 45 years of expertise, Vector Laboratories strikes a perfect balance between stability and the agility of a startup. One of Lisa's biggest challenges as CEO revolves around managing people's adaptability in an ever-changing industry. To tackle this, she prioritizes comprehensive onboarding programs, mentorship opportunities, and community engagement. Lisa also seeks to broaden perspectives by blending community service with coaching and mentoring, collaborating with local schools. Lisa's excitement for the future of life sciences lies in the convergence of genomics and proteomics. She envisions an integrated understanding of biology that paves the way for groundbreaking discoveries. She also emphasizes the importance of being flexible and open to possibilities to navigate the upcoming changes successfully. Don't miss this insightful episode with Lisa V. Sellers, PhD, as we explore her remarkable journey as CEO of Vector Laboratories and gain valuable insights into the future of life sciences. Listen now on the Life Science Success Podcast! 🎧🔬 #LifeScienceSuccess #PodcastEpisode #Leadership #Bioconjugation #FutureOfLifeSciences #Genomics #Proteomics #VectorLaboratories #CEOInsights

Do You know Informuta yet? Check them out one of our latest episodes, in this #StartUpSpotlight #startup #techbio #AI #Biotech

#DYK that millions of #proteoforms with varied dynamics, localization, and function can be made by modifying proteins? These proteoforms can impact our health in myriad ways and are the topic of our new episode of #TranslatingProteomics hosted by Parag Mallick and Andreas Huhmer. Learn about the incredible value of studying proteoforms and how we can routinely measure them to unlock a clearer understanding of biology that will propel #DrugDevelopment and #Biomarker discovery forward: https://ow.ly/Nr2A50SmRQJ 📺 YouTube: https://lnkd.in/gwXpKQ5h   🎧 Apple Podcasts: https://lnkd.in/gET59DHx   🎧 Spotify: https://lnkd.in/gDX6nnDY     #UnleashTheProteome #Proteomics #ProteomicsRevolution #SingleMolecule #MassSpectrometry #TeamMassSpec #Biotech 

As a systems biologist, you learn very quickly how dynamic biology is, and about the complex interplay between different layers of regulation (genome, epigenome, transcriptome, proteome...). At times, the key to understanding regulation of some processes is the change in phosphorylation of a single-site of a single protein. However, examples like histones and the 'histone-code' have shown us how important ensembles of proteoforms (the many molecular forms of a protein product arising from a specific gene) can be in driving the function or malfunction of a system. In the latest episode of Translating Proteomics, Andreas Huhmer and I discuss how and why proteoforms are made, why proteoforms are important, and how a better understanding of them could give rise to a new wave of #biomarkers and precision medicines. Join the conversation and let me know what you think about this important area of biology! https://lnkd.in/dri4BWAk

On the latest episode of “Commercializing Living Therapies with CCRM,” guests Sonia Sennik, Creative Destruction Lab (CDL), and Glenn MacLean, CCRM, discuss how the processes and resources of CDL can help startup founders drive their discoveries to market. CDL’s #advancedtherapies stream, a partnership between CCRM and CDL, supports founders solving biological, medical and health care problems using innovative applications of cell and gene therapies, and other biological products. In this clip, Sonia Sennik speaks about CDL’s emphasis on diverse mentorship for early-stage founders, enabling a venture’s success through collaboration. “CDL very much is focused on the mentorship of early-stage founders. It’s all about setting the right objectives in eight-week cycles and being able to bring in a distributed set of folks with different backgrounds, different experiences, all looking at the same venture and all working together to collaborate on ‘hey, what really are the three most important things that this company should be doing over the next eight weeks?’ If you were to just get that information or just get that advice from one person, you’d be constrained with the experiences of that one mentor. So, a really important part […] of how we run CDL and what we bring together is connecting these mentors together. They collaborate in the small group meetings with the ventures, they speak to them together and, also, in the large room discussions, we have everybody participating in the same conversation with the venture in the room.” Listen wherever you stream podcasts, or at the following link: https://lnkd.in/daTWUkEF #CCRMPodcast

#Proteomics researchers like Neil Kelleher, Judith Steen, Nicholas M. Riley, PhD, and more have shown that knowledge of proteoforms is essential to understanding #biology. In the latest episode of #TranslatingProteomics, Parag Mallick and Andreas Huhmer dive into why proteoforms are so important. Check it out to learn how research into proteoforms can accelerate #biomarker discovery, #drugDevelopment, #biotech, and much more!

Enjoyed sharing on the Alldus #AIinAction podcast how Empress Therapeutics uses natural language processing, causal models, and other #AI and #machinelearning techniques to decode and generate novel chemical compounds from DNA in the pursuit of better small molecule medicines. Thanks JP Valentine for the great discussion!

In #biology class and in popular science stories, we're encouraged to think about DNA and genes as determinants of the rest of biology. DNA and genes are important, but there's a growing movement that recognizes DNA is far from the end of the story and, in most cases, cannot be used to effectively predict or direct what form and function biological systems will take. Proteins on the other hand, direct most biological functions and studying their many complex activities and interactions over biological space and time can vastly advance our understanding of biology. In our new podcast and video series, Translating Proteomics, Nautilus Co-Founder and Chief Scientist, Parag Mallick, and Nautilus Senior Director of Scientific Affairs and Alliance Management, Andreas Huhmer, discuss how #proteomics, the study of all proteins in a biological sample, has matured enough that it's tools can be leveraged to study all manner of biological phenomena at the a molecular, functional, and mechanistic level in a way that will revolutionize how we think about biology. In this first episode of the series, Parag and Andreas discuss why we're poised for proteomics to break into all aspects of biological study. In future episodes, they'll discuss such wide-ranging topics as proteomics and #drugDevelopment, how the proteome changes in space and time, and how proteomics challenges us to refine our thinking about the central dogma of biology. I'm very excited that we're getting this series off the ground and can't wait to hear what you think of it.